中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2013年
4期
1509-1512
,共4页
姜胜莹%曹建彪%范公忍%任永强%韩聚强%李国安%郭汉斌%龚丽娟
薑勝瑩%曹建彪%範公忍%任永彊%韓聚彊%李國安%郭漢斌%龔麗娟
강성형%조건표%범공인%임영강%한취강%리국안%곽한빈%공려연
癌,肝细胞%导管消融术%磷脂酰肌醇蛋白聚糖类%诊断
癌,肝細胞%導管消融術%燐脂酰肌醇蛋白聚糖類%診斷
암,간세포%도관소융술%린지선기순단백취당류%진단
Carcinoma,hepatocellular%Catheter ablation%Glypicans%Diagnosis
目的检测原发性肝细胞癌(HCC)患者射频治疗前后血清中磷脂酰肌醇蛋白聚糖3(GPC3)的含量,初步探讨其在疗效评价中的临床应用价值。方法采用酶联免疫吸附法检测59例HCC患者、35例肝硬化患者、对照组30名健康者血清中GPC3的表达,其中30例HCC患者经射频治疗,对射频治疗前与治疗后1 d、5 d、30 d血清中GPC3含量进行比较,Logistic回归模型进行HCC患者射频治疗后GPC3表达水平波动的危险因素分析。结果 HCC患者血清GPC3含量明显高于肝硬化患者和健康对照组人群,对比三组间的差异有统计学意义( P均<0.01),HCC患者射频治疗后不同时间点GPC3含量较治疗前明显下降( P<0.01),快速复发患者GPC3含量有显著升高波动( P<0.01)。结论 GPC3含量在HCC中表达显著高于肝硬化及正常对照组,特异性好,与AFP表达无明显相关性,联合诊断更有利于提高HCC的诊断敏感性,射频消融治疗后不同阶段GPC3均有不同程度降低,GPC3浓度的变化与快速复发有关,在疗效评估及预后判断有一定临床价值。
目的檢測原髮性肝細胞癌(HCC)患者射頻治療前後血清中燐脂酰肌醇蛋白聚糖3(GPC3)的含量,初步探討其在療效評價中的臨床應用價值。方法採用酶聯免疫吸附法檢測59例HCC患者、35例肝硬化患者、對照組30名健康者血清中GPC3的錶達,其中30例HCC患者經射頻治療,對射頻治療前與治療後1 d、5 d、30 d血清中GPC3含量進行比較,Logistic迴歸模型進行HCC患者射頻治療後GPC3錶達水平波動的危險因素分析。結果 HCC患者血清GPC3含量明顯高于肝硬化患者和健康對照組人群,對比三組間的差異有統計學意義( P均<0.01),HCC患者射頻治療後不同時間點GPC3含量較治療前明顯下降( P<0.01),快速複髮患者GPC3含量有顯著升高波動( P<0.01)。結論 GPC3含量在HCC中錶達顯著高于肝硬化及正常對照組,特異性好,與AFP錶達無明顯相關性,聯閤診斷更有利于提高HCC的診斷敏感性,射頻消融治療後不同階段GPC3均有不同程度降低,GPC3濃度的變化與快速複髮有關,在療效評估及預後判斷有一定臨床價值。
목적검측원발성간세포암(HCC)환자사빈치료전후혈청중린지선기순단백취당3(GPC3)적함량,초보탐토기재료효평개중적림상응용개치。방법채용매련면역흡부법검측59례HCC환자、35례간경화환자、대조조30명건강자혈청중GPC3적표체,기중30례HCC환자경사빈치료,대사빈치료전여치료후1 d、5 d、30 d혈청중GPC3함량진행비교,Logistic회귀모형진행HCC환자사빈치료후GPC3표체수평파동적위험인소분석。결과 HCC환자혈청GPC3함량명현고우간경화환자화건강대조조인군,대비삼조간적차이유통계학의의( P균<0.01),HCC환자사빈치료후불동시간점GPC3함량교치료전명현하강( P<0.01),쾌속복발환자GPC3함량유현저승고파동( P<0.01)。결론 GPC3함량재HCC중표체현저고우간경화급정상대조조,특이성호,여AFP표체무명현상관성,연합진단경유리우제고HCC적진단민감성,사빈소융치료후불동계단GPC3균유불동정도강저,GPC3농도적변화여쾌속복발유관,재료효평고급예후판단유일정림상개치。
Objective To detect the concentration of Glypican-3 ( GPC3 ) in serum before and after the radiofrequency ablation(RFA)for hepatocellular carcinoma(HCC)patients,and investigate its clinical value in the efficacy evaluation initially.Methods The concentration of serum GPC3 in 59 patients with HCC,35 patients with cirrhosis and 30 healthy control subjects were assayed with ELISA , and the GPC3 levels in their serum of before-treat,1-day,5-day and 30-day after RFA were compared .The principal risk factors of the fluctuation of GPC 3 content in the patients with HCC after RFA was analyzed by logistic regression model .Results The content of GPC3 in serum of HCC patients was significantly higher than that of cirrhosis patients and the healthy control group crowd ( P<0.01 ) ,and the GPC3 content of HCC patients in different time after the RFA treatment was decreased contrasted with that before treatment ( P <0.01 ) , which of the patients with little survivorship and rapid recurrence had significant fluctuation of step-up( P<0.01 ) .Conclusions There were high detection and specificity of GPC 3 in HCC compared with cirrhosis and the healthy control group , with no significant correlation to AFP expression .The joint diagnosis was much more conducive to improving the diagnostic sensitivity of HCC .The levels of GPC3 in different time after RFA were all reduced to some degree , which was concerned with little survivorship and rapid recurrence.Therefore,the detection of GPC3 possessed good clinical application value .